Mivavotinib

CAS : 1312691-33-0

Ref. 3D-MCC69133

Informations sur le produit

• Nom: Mivavotinib
• Marque: Biosynth
• Description: Mivavotinib is a potent inhibitor of the Src family tyrosine kinase Shp2. It has been shown to be effective in treating cancer patients with malignant tumors or who are at high risk of developing a tumor. Mivavotinib has also been shown to have beneficial effects in patients with autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. The drug works by binding to the SHP2 protein, which prevents it from associating with other proteins and blocks its activity. This inhibition leads to the prevention of cell proliferation and the promotion of cancer cell death. The structural formula for mivavotinib is shown below:

Propriétés chimiques

• Masse moléculaire: 344.4 g/mol
• Formule: C₁₇H₂₁FN₆O
• Degré de pureté: Min. 95%